Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
64,670,984
-
Total 13F shares
-
58,306,002
-
Share change
-
+4,047,394
-
Total reported value
-
$536,933,982
-
Put/Call ratio
-
4%
-
Price per share
-
$9.21
-
Number of holders
-
171
-
Value change
-
+$27,282,114
-
Number of buys
-
90
-
Number of sells
-
83
Institutional Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) as of Q2 2025
As of 30 Jun 2025,
Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,306,002 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Nantahala Capital Management, LLC, BlackRock, Inc., Caligan Partners LP, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Frazier Life Sciences Management, L.P., Soleus Capital Management, L.P., FRONTIER CAPITAL MANAGEMENT CO LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
171
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.